COMBIMATRIX Aktie

0,71 EUR 8,3587%

Zu Ihrem Onlinebroker

kaufen verkaufen

COMBIMATRIX Aktienkurs : 25.05. ( 15 Min. verzögert)
0,713 € Letzter Kurs	8,36% Veränderung	0,658 € Vortag	0,713 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
0,713 - 0,658 Tag	2,58 - 0,644 52 Wochen	0 Tag	12 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

COMBIMATRIX Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

15.05.

Array-Based Tests Advance as Dx Firms Engage FDA, Raise Capital, Report ...

As Courtagen and SQI made progress in building their businesses, both GenMark Diagnostics and CombiMatrix, firms that already have tests on the market, saw their first quarter revenues spike. Carlsbad, Calif.-based GenMark led the way,...
15.05.

The 'Other' IPO To Start Trading This Week

Some of the larger companies involved in genetics diagnostic sales or research are CombiMatrix (CBMX), Quest Diagnostics (DGX), Abbott Laboratories (ABT), Johnson & Johnson (JNJ), Roche Molecular Systems (RHHBY), Genomic Health (GHDX), Myriad Genetics...

11.05.

DIARY - US Company Conference Call/Webcast for Day Ahead

... Q1 Biofuel Energy Corp Erngs Conf Call 11 May 15:00 Q1 Bonanza Creek Energy Erngs Conf Call 11 May 15:00 Q1 Combimatrix Erngs Conf Call 11 May 15:00 Q1 Gold Resource ...
11.05.

DIARY-NON S&P WEEK AHEAD

... Bridgeline Digital Inc -0.01 1 N/A 11 May BMO Q1 2012 Cache, Inc. -0.09 3 -0.06 11 May BMO Q1 2012 Combimatrix -0.30 1 N/A 11 May Q1 2012 Chaparral Energy, ...
11.05.

CombiMatrix Corporation Reports First Quarter 2012 Financial Results

IRVINE, Calif., May 11, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, reported today that total revenues...